Insulet PODD
NASDAQ PODD
$148.85 -2.66 (-1.76%)
At close: Aug 20, 2026 · 2:20 PM UTC

Insulet (PODD) Non-Current Deferred Tax Liability (2011 - 2012)

Insulet's (PODD) quarterly Non-Current Deferred Tax Liability came in at $700000.0 in Q4 2012, down 22.22% YoY from $900000.0 in Q1 2012, and down 30.0% on a QoQ basis from $1.0 million in Q3 2012.

Insulet (PODD) Non-Current Deferred Tax Liability (2011 - 2012) Analysis & Trends

Insulet (PODD) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $700000.0 in Q4 2012.

  • Quarterly Non-Current Deferred Tax Liability fell 22.22% year-over-year to $700000.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $700000.0 (down 22.22% YoY) and the FY2012 annual result came in at $700000.0, down 22.22% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $700000.0 in Q4 2012, from $1.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $5.5 million in Q2 2011 to a low of $700000.0 in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn
10 Insulet 10.34 Bn 9.80 Bn 562.60 Mn

Historic Data

Download Data
DateValue
Dec 31, 2012 700,000.00
Dec 31, 2012 700,000.00
Sep 30, 2012 1.00 Mn
Sep 30, 2012 1.00 Mn
Jun 30, 2012 1.00 Mn
Jun 30, 2012 1.00 Mn
Mar 31, 2012 900,000.00
Mar 31, 2012 900,000.00
Dec 31, 2011 900,000.00
Dec 31, 2011 900,000.00
Jun 30, 2011 5.50 Mn
Jun 30, 2011 5.50 Mn